Skip to content

Dr. Jessica Manson discusses multidisciplinary HLH management at SOHO UK
Why clinicians should lead hospitals, according to Prof. Amanda Goodall
China NMPA approves pirtobrutinib in relapsed/refractory CLL/SLL
FDA accepts NDA for iberdomide in relapsed/refractory myeloma
Drs. Zhang and Bona discuss financial toxicity in pediatric oncology

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

SOHO MENA returns to in-person meeting for region’s 3rd meeting

Cellular Therapy

SOHO MENA returns to in-person meeting for region’s 3rd meeting

Leukemia

SOHO MENA returns to in-person meeting for region’s 3rd meeting

Lymphoma

SOHO MENA returns to in-person meeting for region’s 3rd meeting

Multiple Myeloma

SOHO MENA returns to in-person meeting for region’s 3rd meeting

Myelodysplastic Syndromes

SOHO MENA returns to in-person meeting for region’s 3rd meeting

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

March 12, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Hem/Onc Library Myelodysplastic Syndromes

MDS News

Presenter speaking

Ambassador Program Myelodysplastic Syndromes Society Updates

SOHO MENA returns to in-person meeting for region’s 3rd meeting

by SOHO Insider Editors
October 20, 2025
0 Comments

Uma Borate presentation

SOHO 2025 Educational Resources Leukemia Meetings / Conferences Myelodysplastic Syndromes News

Improving Outcomes in CHIP/CCUS with Dr. Borate

by SOHO Insider Editors
October 20, 2025
0 Comments

FDA stamp on white paper

Leukemia Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Myelodysplastic Syndromes News

FDA accepts BLA for Orca-T in hematological malignancies

by SOHO Insider Editors
October 15, 2025
0 Comments

Time for Phase 2. Hand holds a cube with number '2'. Word 'Phase 2'. Beautiful black background. Business concept. Copy space.

Acute Myeloid Leukemia Myelodysplastic Syndromes

Oral decitabine and cedazuridine combo shows promise as post-HSCT option

by Leah Sherwood
August 21, 2025
0 Comments

a globe

Acute Myeloid Leukemia Myelodysplastic Syndromes

Treatment post-relapse improves survival outcomes in patients with AML or MDS

by SOHO Insider Editors
August 11, 2025
0 Comments

SOHO Insider podcast

SOHO 2025 Meeting News Myelodysplastic Syndromes News SOHO Insider Podcast

SOHO President Phillip Scheinberg talks with Saad Usmani on SOHO 2025

by Leah Sherwood
July 23, 2025
0 Comments

cancer cells

Acute Myeloid Leukemia Myelodysplastic Syndromes News

Combo eprenetapopt plus azacitidine is well-tolerated in TP53-mutated MDS and AML

by SOHO Insider Editors
July 22, 2025
0 Comments

Organization structure, social network and teamwork concept on dark background. Business people icon on wooden cube blocks connecting network of connections.

Myelodysplastic Syndromes

Study identifies nonmutational p53 dysfunction as MDS risk factor

by Leah Sherwood
May 13, 2025
0 Comments

FDA Green light

Myelodysplastic Syndromes

FDA grants Orphan Drug Designation for bexmarilimab in MDS

by SOHO Insider Editors
May 12, 2025
0 Comments

European Commission

Myelodysplastic Syndromes

EC approves imetelstat for transfusion-dependent anemia in lower-risk MDS

by Leah Sherwood
March 17, 2025
0 Comments

1
2
3

Top Categories

Cellular Therapy

54

Leukemia

90

Lymphoma

95

Multiple Myeloma

81

Myelodysplastic Syndromes

30

Myeloproliferative Neoplasms

19

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

EC approves imetelstat for transfusion-dependent anemia in lower-risk MDS

Cellular Therapy

EC approves imetelstat for transfusion-dependent anemia in lower-risk MDS

Leukemia

EC approves imetelstat for transfusion-dependent anemia in lower-risk MDS

Lymphoma

EC approves imetelstat for transfusion-dependent anemia in lower-risk MDS

Multiple Myeloma

EC approves imetelstat for transfusion-dependent anemia in lower-risk MDS

Myelodysplastic Syndromes

EC approves imetelstat for transfusion-dependent anemia in lower-risk MDS

Myeloproliferative Neoplasms

Subscribe

Recent Posts

Dr. Jessica Manson

Dr. Jessica Manson discusses multidisciplinary HLH management at SOHO UK

SOHO Insider podcast

Why clinicians should lead hospitals, according to Prof. Amanda Goodall

Chinese flag

China NMPA approves pirtobrutinib in relapsed/refractory CLL/SLL

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.